CAIRNSURGICAL, INC.

Hanover, NH · Founded 2017 · Medtech · Private

Breast Cancer Locator (BCL), a patient-specific surgical guidance device for breast-conserving surgery that replaces wire localization to reduce positive margin rates

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Hanover, NH
Founded
2017
Latest Form D
$3.3M, Dec 2019
Total capital
$12.8M
Federal grants
$9.5M
8 awards · 2016–2021
Rank in peer group#48 of 538
Private capital raised
$3.3M
1 Form D · last Dec 2019
82 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
6 pending · first 2020
Rank in peer group#190 of 538

Capital timeline

201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $12.8M$2M$970K$2M$2M$1.1M$992K1st Form D$3.3M
201620172018201920202021FEDERAL ↑EQUITY ↓Cumulative $12.8M$2M$2M$2M$1.1M1st Form D$3.3M

Latest events

  • Federal grantHealth and Human S · Phase II · Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer$992K
  • Federal grantHealth and Human S · Phase II · Supine Breast MRI Standardization for Breast Cancer Locator$1.1M
  • Federal grantHealth and Human S · Phase II · Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer$2M
  • Private capital raisedForm D · SEC · 1st filing$3.3M
  • Federal grantHealth and Human S · Phase II · Supine Breast MRI Standardization for Breast Cancer Locator$2M
  • Federal grantHealth and Human S · Phase II · Supine Breast MRI Standardization for Breast Cancer Locator$221K
  • Federal grantHealth and Human S · Phase II · Breast Cancer Locator$970K
Show 2 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Breast Cancer Locator$2M
  • Federal grantHealth and Human S · Phase I · Breast Cancer Locator$209K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

42months

from CAIRNSURGICAL, INC.’s first federal award to its first private round.

First federal award · Jul 2016
Health and Human S · $209K
First Form D · Dec 2019
$3.3M · 1st Form D
Awards before first raise
5 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#48 · top 9%
  • Granted patents#190 · top 35%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Aaron KaplanDirectorNamed in SEC Form D filings
  • Bernard LyonsDirectorNamed in SEC Form D filings
  • David DanielsenExecutive Officer, DirectorNamed in SEC Form D filings
  • Jake RederDirectorNamed in SEC Form D filings
  • Keith PaulsenDirectorNamed in SEC Form D filings
  • Richard BarthDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 8
Show all 8 patent records
  • Devices For Guiding Tissue Treatment And/or Tissue Removal ProceduresApr 12, 2022 · US 11,298,205Granted
  • Devices For Guiding Tissue Treatment And/or Tissue Removal ProceduresFeb 11, 2020 · US 10,555,791Granted
  • Support Devices For Medical Imaging ProceduresNov 21, 2019 · Application 16437896Pending
  • Support Devices For Medical Imaging ProceduresNov 21, 2019 · Application 16437866Pending
  • Devices For Guiding Tissue Treatment And/or Tissue Removal ProceduresApplication PCTUS2019029708Pending
  • Support Devices For Medical Imaging ProceduresApplication PCTUS2019027315Pending
  • Support Devices For Medical Imaging ProceduresApplication 62671597Pending
  • Devices For Guiding Tissue Treatment And/or Tissue Removal ProceduresApplication 62671609Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .